Biotech

All Articles

Genentech to shut cancer cells immunology study department

.Genentech will close its own cancer immunology study department, as well as unit mind and also well...

Kezar drops strong growth yet to prove its well worth in phase 1 test

.Kezar Lifestyle Sciences is dropping its unpromising period 1 strong tumor medicine as the biotech ...

Acelyrin falls izokibep, drops 3rd of personnel

.Even with izokibep maintaining its newfound winning streak in the center, Acelyrin is no longer foc...

Rivus' stage 2 obesity-related heart failure trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medication pr...

Ovid stops preclinical work, IV course after soticlestat neglect

.Ovid Therapy already exposed last month that it was trimming back its own headcount as the company ...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD center in the Boston ma Port, increasing it...

Boundless Biography makes 'small' cutbacks 5 months after $100M IPO

.Only 5 months after securing a $one hundred million IPO, Limitless Bio is actually already laying o...

Halda's $126M is going to advance 'hold and also get rid of' lump drugs

.The preliminary stages of oncology R&ampD aren't except appealing new methods, and also Halda Rehab...

Lykos 'disappointments' certainly not revealing study violations along with publisher

.Psychopharmacology has actually drawn three posts about midstage professional test information dete...

Analysts explore Avidity's DMD gain, disclosing nuances in data

.Avidity Biosciences pleased entrepreneurs with period 1/2 information in Duchenne muscular dystroph...